2 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Symphogen Competitors or Alternatives

Symphogen's top competitors include Juno Therapeutics, NexImmune and Sutro Biopharma.

Unlock 13 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Symphogen's company profile

Christophe Thurieau

CEO

90/100
100 - 250
$76.6M
$25M - 100M
  • $76.6M
    $25M - 100M
  • 100 - 250
    $76.6M
  • $25M - 100M
  • 90/100
  • 100 - 250
  • $76.6M
  • $25M - 100M
View ProfileView
1
Symphogen's Competitor - Juno Therapeutics logo

CEO

- -
1,000 - 5,000
$1.5B
$100M - 500M
  • $1.5B
    $100M - 500M
  • 1,000 - 5,000
    $1.5B
  • $100M - 500M
  • - -
  • 1,000 - 5,000
  • $1.5B
  • $100M - 500M
View ProfileView
2
Symphogen's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
70
$166.4M
  • $166.4M
  • 70
    $166.4M
  • 86/100
  • 70
  • $166.4M
View ProfileView
3
Symphogen's Competitor - Sutro Biopharma logo

CEO

- -
240
$570.3M
$105.6M
  • $570.3M
    $105.6M
  • 240
    $570.3M
  • $105.6M
  • - -
  • 240
  • $570.3M
  • $105.6M
View ProfileView
4
Symphogen's Competitor - Perthera logo

Donna Tuths

President & CEO

82/100
25 - 100
$17.9M
$100K - 5M
  • $17.9M
    $100K - 5M
  • 25 - 100
    $17.9M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $17.9M
  • $100K - 5M
View ProfileView
5
Symphogen's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
520
$821.4M
$103.9M
  • $821.4M
    $103.9M
  • 520
    $821.4M
  • $103.9M
  • 73/100
  • 520
  • $821.4M
  • $103.9M
View ProfileView
Symphogen's top 16 competitors are Juno Therapeutics, NexImmune, Sutro Biopharma, Aura, Perthera, bluebird bio, Jounce, CR Pharmaceutical, Bavarian Nordic, STipe, Metabomed, Novartis, Azanta, Amgen, Apexigen and Cedilla. Together they have raised over 8.6B between their estimated 177.8K employees. Symphogen's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 9B. Symphogen has 108 employees and is ranked 9th among it's top 10 competitors. The top 10 competitors average 10,467.

Symphogen VS Juno Therapeutics

Juno Therapeutics is Symphogen's top competitor. Juno Therapeutics was founded in 2013 in Seattle, Washington. Juno Therapeutics competes in the Biotechnology field. Juno Therapeutics generates $80.9M more revenue than Symphogen.

Symphogen VS NexImmune

NexImmune is perceived as one of Symphogen's biggest rivals. NexImmune's headquarters is in Gaithersburg, Maryland, and was founded in 2011. Like Symphogen, NexImmune also competes in the Biotechnology industry. NexImmune generates NaN% of Symphogen's revenue.

Symphogen VS Sutro Biopharma

Sutro Biopharma is one of Symphogen's top competitors. Sutro Biopharma is a Public company that was founded in South San Francisco, California in 2003. Like Symphogen, Sutro Biopharma also competes in the Biotechnology field. Sutro Biopharma has 132 more employees vs. Symphogen.

Looking for similar companies to Symphogen?

Similar Companies

Pharmaceuticals companies in Denmark

See 149 companies 
Companies in Denmark with revenue in $25-100M range

See 359 companies 
Biotechnology companies in Denmark

See 218 companies 
Pharmaceuticals & Biotechnology companies in Denmark

See 372 companies 
Companies in Denmark with employees in 100-250 range

See 406 companies 
Pharmaceuticals companies with employees in 100-250 range

See 813 companies 
Pharmaceuticals companies with revenue in $25-100M range

See 840 companies 
Biotechnology companies with revenue in $25-100M range

See 881 companies 
Biotechnology companies with employees in 100-250 range

See 1,119 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Symphogen and Symphogen's Competitors

January 16, 2026Seeking Alpha
Today 12:37 PMLife Care News
Basel, January 16, 2026 - Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ianal...
January 15, 2026PMLiVE
Around 64 million people worldwide live with psoriasis...

Frequently Asked Questions about Symphogen

  1. Who are Symphogen's top competitors?

    Symphogen's top 3 competitors are Juno Therapeutics, NexImmune, Sutro Biopharma.

  2. Who is similar to Symphogen?

    Juno Therapeutics is the most similar to Symphogen. NexImmune and Sutro Biopharma are also similar to Symphogen.

  1. Are Symphogen and Juno Therapeutics competitors?

    Yes, Juno Therapeutics is one of Symphogen’s top competitors.